Estrella Immunopharma logo

Estrella ImmunopharmaNASDAQ: ESLA

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

14 September 2021

Next earnings report:

14 February 2025

Last dividends:

N/A

Next dividends:

N/A
$34.08 M
-72%vs. 3y high
30%vs. sector
-vs. 3y high
-vs. sector
-26%vs. 3y high
99%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | 31 min ago
$0.94+$0.05(+5.83%)

Dividend

No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

What type of business is Estrella Immunopharma?

Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California.

What sector is Estrella Immunopharma in?

Estrella Immunopharma is in the Healthcare sector

What industry is Estrella Immunopharma in?

Estrella Immunopharma is in the Biotechnology industry

What country is Estrella Immunopharma from?

Estrella Immunopharma is headquartered in United States

When did Estrella Immunopharma go public?

Estrella Immunopharma initial public offering (IPO) was on 14 September 2021

What is Estrella Immunopharma website?

https://www.estrellabio.com

Is Estrella Immunopharma in the S&P 500?

No, Estrella Immunopharma is not included in the S&P 500 index

Is Estrella Immunopharma in the NASDAQ 100?

No, Estrella Immunopharma is not included in the NASDAQ 100 index

Is Estrella Immunopharma in the Dow Jones?

No, Estrella Immunopharma is not included in the Dow Jones index

When was Estrella Immunopharma the previous earnings report?

No data

When does Estrella Immunopharma earnings report?

The next expected earnings date for Estrella Immunopharma is 14 February 2025